<code id='9B722D1B82'></code><style id='9B722D1B82'></style>
    • <acronym id='9B722D1B82'></acronym>
      <center id='9B722D1B82'><center id='9B722D1B82'><tfoot id='9B722D1B82'></tfoot></center><abbr id='9B722D1B82'><dir id='9B722D1B82'><tfoot id='9B722D1B82'></tfoot><noframes id='9B722D1B82'>

    • <optgroup id='9B722D1B82'><strike id='9B722D1B82'><sup id='9B722D1B82'></sup></strike><code id='9B722D1B82'></code></optgroup>
        1. <b id='9B722D1B82'><label id='9B722D1B82'><select id='9B722D1B82'><dt id='9B722D1B82'><span id='9B722D1B82'></span></dt></select></label></b><u id='9B722D1B82'></u>
          <i id='9B722D1B82'><strike id='9B722D1B82'><tt id='9B722D1B82'><pre id='9B722D1B82'></pre></tt></strike></i>

          hotspot

          hotspot

          author:entertainment    Page View:73792
          A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

          Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

          Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron. 

          advertisement

          “It has been exciting to be involved,” Gorham wrote. 

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more
          Why failed clinical trials don’t always spell doom for a new drug
          Why failed clinical trials don’t always spell doom for a new drug

          AdobeThisarticlewasadaptedfromSTAT’slatestreport,“Failedtrial,successfuldrug:howanegativereadoutcans

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          DeSantis says Trump could've 'come out more forcefully' during Jan. 6

          2:27FloridaGov.RonDeSantisrollsouthismilitarypolicyproposalduringaneventforhis2024presidentialcampai